Accumulating evidence has strongly linked TEAD1 disruption or MST kinases activation to many diseases, such as Sveinsson's chorioretinal atrophy, AC, AD, skeletal muscle atrophy, ALS and diabetes. This evidence concerns the gene TEAD1 and muscular atrophy.